SCHEMBL5232248

SCHEMBL5232248

CC(C)(C)OC(=O)NC1(C2CC(=O)N(Cc3ccccc3)C2)CC(F)(F)C1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
TSHR P16473 2/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KMT2A Q03164 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SCN9A Q15858 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
HPGD P15428 1/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
GLA P06280 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
P2RX7 Q99572 1/20 0.41
PKM P14618 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5236800 0.89 ALDH1A1 (0.43) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL4671695 0.89 KMT2A (0.45) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL5233534 0.89 ALDH1A1 (0.44) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL5238965 0.88 ALDH1A1 (0.43) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL5233429 0.84 ALDH1A1 (0.41) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL5235530 0.83 KMT2A (0.44) ALDH1A1KMT2AL3MBTL1RAB9ATDP1
SCHEMBL5235899 0.78 KMT2A (0.41) ALDH1A1TSHRMAPK1KMT2AL3MBTL1
SCHEMBL6167072 0.76 ALDH1A1 (0.44) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL5425216 0.76 KMT2A (0.60) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL6865331 0.76 KMT2A (0.60) ALDH1A1TSHRMAPK1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0990654-B1 SUBSTITUTED CYCLOBUTYLAMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2007-11-14 EP disclosed
US-6448266-B1 COMPOUNDS SUCH AS 2-AMINO-7-(3-(3-AMINO-1-FLUOROCYCLOBUTAN-3-YL)PYRROLIDIN-1-YL)-6-FLUORO-1-(2-FLUORO-1-CYCLOPROPYL)-8-METHYL-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS, PNEUMOCOCCUS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-09-10 US disclosed
EP-0990654-A1 SUBSTITUTED CYCLOBUTYLAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed